4113 Share Price Performance
NT$22.30
-9.85 (-30.64%)
Price NT$22.30
Share PriceNT$22.30
We & Win Diversification Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
4113 Community Narratives
There are no narratives available yet.
Recent 4113 News & Updates
We & Win Diversification Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.90
- Gross Margin
- 20.81%
- Net Profit Margin
- 7.59%
- Debt/Equity Ratio
- 202.9%
We & Win Diversification Co., Ltd. Competitors
Snowflake Analysis
About 4113
- Founded
- 1987
- Employees
- 36
- CEO
- WebsiteView website
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Taiwanese Market Performance
- 7 Days: 1.9%
- 3 Months: 19.3%
- 1 Year: 17.3%
- Year to Date: 18.3%
Over the last 7 days, the market has risen 1.9%, driven by gains of 2.2% in the Information Technology sector. As for the past 12 months, the market is up 17%. As for the next few years, earnings are expected to grow by 18% per annum. Market details ›